Values as of: 2021-12-07
Last Closing Price
HKD 24.14Change
+0.64 (+2.72)%Market Cap
HKD 95.43BVolume
0.12BYahoo Analyst Target
N/AAvg Analyst Target
N/A
N/A
Verdict
Tracker Fund Of Hong Kong is an exchange traded fund launched and managed by State Street Global Advisors Asia Limited. It invests in the public equity markets of Hong Kong. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in th ...Read More
Company Website : http://www.ssga.com.hk
Currency: HKD
Country : Hong Kong
Management Expense Ratio: 0.00 %
Beta : 0.78
52 Week High : 31.34
52 Week Low : 23.30
200 Day Moving Average : 27.39
50 Day Moving Average : 25.31
N/A
N/A
N/A
Category Benchmark : Hang Seng HSI GR HKD
Sustainability Ratio : 4
3 Year Volatility : 0.00
3 Year Expected Return : 0.00
3 Year Sharpe Ratio : 0.00
YTD Return : -9.42%
3 Year Returns : -1.32%
5 Year Returns : 2.11%
10 Year Returns : 8.73%
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| 2833:HK | Hang Seng Investment Index Fun.. | 0.00 % |
+0.62 (+2.61%) |
HKD30.97B |
| 2828:HK | Hang Seng Investment Index Fun.. | 0.00 % |
+2.50 (+2.98%) |
HKD21.03B |
| 83188:HK | ChinaAMC CSI 300 Index ETF | 0.00 % |
+0.42 (+0.84%) |
HKD14.89B |
| 2823:HK | iShares Asia Trust - iShares F.. | 0.00 % |
+0.18 (+0.97%) |
HKD14.41B |
| 82822:HK | CSOP FTSE China A50 ETF | 0.00 % |
+0.16 (+1.08%) |
HKD9.76B |
| 2801:HK | iShares Asia Trust - iShares C.. | 0.00 % |
+0.84 (+3.15%) |
HKD4.33B |
| 0801:HK | Golden Meditech Holdings Limit.. | 0.00 % |
N/A |
HKD2.54B |
| 3010:HK | iShares Asia Trust - iShares C.. | 0.00 % |
+1.04 (+1.70%) |
HKD2.50B |
| 2819:HK | ABF Hong Kong Bond Index Fund | 0.21 % |
+0.10 (+0.10%) |
HKD2.31B |
| 3081:HK | Value Gold ETF | 0.00 % |
-0.08 (-0.19%) |
HKD1.79B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|
N/A
| Market Performance vs. Industry/Classification (Others) |
Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -11.90% | 40% | F | 37% | F | ||
| Dividend Return | 2.45% | 39% | F | 31% | F | ||
| Total Return | -9.45% | 41% | F | 37% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -8.77% | 40% | F | 39% | F | ||
| Dividend Return | 2.53% | 37% | F | 29% | F | ||
| Total Return | -6.24% | 41% | F | 40% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 4.96% | 22% | F | 72% | C- | ||
| Dividend Return | 18.00% | 96% | A | 61% | D- | ||
| Total Return | 22.96% | 32% | F | 74% | C | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 2.47% | 46% | F | 58% | F | ||
| Dividend Return | 3.15% | 96% | A | 62% | D- | ||
| Total Return | 5.62% | 54% | F | 61% | D- | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 14.49% | 62% | D- | 84% | B | ||
| Risk Adjusted Return | 38.81% | 53% | F | 73% | C | ||
| Market Capitalization | 95.43B | 100% | A+ | 94% | A | ||
| Letter Grade | Percentage | Letter Grade | Percentage | Letter Grade | Percentage |
| A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
| B+ | 87%-89% | B | 83%-86% | B- | 80%-82% |
| C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
| D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
| F | 0%-59% |
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
No discussions yet
| User Name | Target Rating | Target Horizon (Months) | Target Price | User Analysis | Date | Comment |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
There is nothing we particularly dislike
Do not have an account? Register here
